amlodipine has been researched along with Hyperemia in 7 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Hyperemia: The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings suggest that the ACE inhibitor imidapril augments RH after 12 weeks of treatment in patients with essential hypertension and that this ACE inhibitor-induced augmentation of RH may be due to an increase in NO." | 7.71 | Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function. ( Higashi, Y; Kajiyama, G; Matsuura, H; Nakagawa, K; Oshima, T; Sasaki, S, 2001) |
| " Forearm blood flow (FBF) was measured in 69 patients with essential hypertension (mild, n = 23; moderate, n = 29; and severe, n = 17 randomly assigned to treatment with either imidapril or amlodipine for 24 weeks in a double-blind fashion during reactive hyperemia and after sublingual administration of nitroglycerin." | 5.10 | Severity of hypertension affects improved resistance artery endothelial function by angiotensin-converting enzyme inhibition. ( Chayama, K; Goto, C; Hara, K; Higashi, Y; Kimura, M; Matsuura, H; Nakagawa, K; Noma, K; Oshima, T; Sasaki, S, 2002) |
| "These findings suggest that the ACE inhibitor imidapril augments RH after 12 weeks of treatment in patients with essential hypertension and that this ACE inhibitor-induced augmentation of RH may be due to an increase in NO." | 3.71 | Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function. ( Higashi, Y; Kajiyama, G; Matsuura, H; Nakagawa, K; Oshima, T; Sasaki, S, 2001) |
| "Hypertension is the major risk factor for SVDs, but how hypertension damages the brain microcirculation is unclear." | 1.62 | Differential restoration of functional hyperemia by antihypertensive drug classes in hypertension-related cerebral small vessel disease. ( Dabertrand, F; Ferris, HR; Greenstein, AS; Harraz, OF; Hill-Eubanks, DC; Koide, M; Longden, TA; Nelson, MT; Wellman, GC, 2021) |
| "Forearm vasodilatory response to reactive hyperemia was improved by temocapril (102 +/- 20% to 168 +/- 25%, P < ." | 1.30 | Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension. ( Hata, T; Higaki, J; Iwatsubo, H; Kumamoto, K; Morita, R; Nagano, M; Ogihara, T; Sakai, T, 1997) |
| " The chronic administration of benazepril (5-10 mg/d) for 20 weeks improved insulin sensitivity, endothelial function (6." | 1.30 | Relationship between endothelial function and fibrinolysis in early hypertension. ( Doba, N; Kimura, Y; Kinouchi, T; Kushiro, T; Mitsuhashi, H; Tomiyama, H; Yoshida, H, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Koide, M | 1 |
| Harraz, OF | 1 |
| Dabertrand, F | 1 |
| Longden, TA | 1 |
| Ferris, HR | 1 |
| Wellman, GC | 1 |
| Hill-Eubanks, DC | 1 |
| Greenstein, AS | 1 |
| Nelson, MT | 1 |
| Felmeden, DC | 1 |
| Blann, AD | 1 |
| Spencer, CG | 1 |
| Beevers, DG | 1 |
| Lip, GY | 1 |
| Okuro, M | 1 |
| Morimoto, S | 1 |
| Takahashi, T | 1 |
| Okaishi, K | 1 |
| Nakahashi, T | 1 |
| Murai, H | 1 |
| Iwai, K | 1 |
| Kanda, T | 1 |
| Matsumoto, M | 1 |
| Iwatsubo, H | 1 |
| Nagano, M | 1 |
| Sakai, T | 1 |
| Kumamoto, K | 1 |
| Morita, R | 1 |
| Higaki, J | 1 |
| Ogihara, T | 1 |
| Hata, T | 1 |
| Tomiyama, H | 1 |
| Kimura, Y | 1 |
| Mitsuhashi, H | 1 |
| Kinouchi, T | 1 |
| Yoshida, H | 1 |
| Kushiro, T | 1 |
| Doba, N | 1 |
| Higashi, Y | 2 |
| Sasaki, S | 3 |
| Nakagawa, K | 2 |
| Matsuura, H | 2 |
| Kajiyama, G | 1 |
| Oshima, T | 2 |
| Kimura, M | 1 |
| Noma, K | 1 |
| Hara, K | 1 |
| Goto, C | 1 |
| Chayama, K | 1 |
3 trials available for amlodipine and Hyperemia
| Article | Year |
|---|---|
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes T
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Brachial Artery; Card | 2003 |
Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis Obli | 2006 |
Severity of hypertension affects improved resistance artery endothelial function by angiotensin-converting enzyme inhibition.
Topics: Adult; Amlodipine; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2002 |
4 other studies available for amlodipine and Hyperemia
| Article | Year |
|---|---|
Differential restoration of functional hyperemia by antihypertensive drug classes in hypertension-related cerebral small vessel disease.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cerebral Smal | 2021 |
Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calci | 1997 |
Relationship between endothelial function and fibrinolysis in early hypertension.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Brachial | 1998 |
Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Endothelium, Vascular; Female; Forearm; | 2001 |